GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | 9/18/2026 4:34:44 PM | View | Proxy | SEC | Y 2026 | ||||||
| Neuphoria Therapeutics Inc. (NEUP) | 9/18/2026 4:23:56 PM | Micro | View | Financials | 10-K | SEC | Y 2026 ending: 6/30/2026 | Rev: $1,174,165 -92.5% | Assets $28,709,016 | EPS -$3.06 | |
| Neuphoria Therapeutics Inc. (NEUP) | 5/15/2026 8:46:42 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2026 ending: 3/31/2026 | Assets $34,809,200 | EPS -$0.09 | ||
| Neuphoria Therapeutics Inc. (NEUP) | 2/17/2026 4:04:17 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 12/31/2025 | Assets $36,598,302 | EPS -$0.77 | ||
| Neuphoria Therapeutics Inc. (NEUP) | 11/24/2025 11:16:51 AM | View | Proxy | SEC | Y 2025 | ||||||
| Neuphoria Therapeutics Inc. (NEUP) | 11/24/2025 10:20:33 AM | View | Proxy | SEC | Y 2025 | ||||||
| Neuphoria Therapeutics Inc. (NEUP) | 11/14/2025 7:43:19 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 9/30/2025 | Assets $27,343,913 | EPS -$4.41 | ||
| Neuphoria Therapeutics Inc. (NEUP) | 10/30/2025 6:06:21 AM | View | Proxy | SEC | Y 2025 | ||||||
| Neuphoria Therapeutics Inc. (NEUP) | 9/29/2025 4:57:20 PM | View | Financials | Earnings | WIRE | Y 2025 | Rev ($13,267) | Assets $28,589,614 | EPS -$3.98 | Export Earnings Model | |
| Neuphoria Therapeutics Inc. (NEUP) | 9/29/2025 4:53:41 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 6/30/2025 | Rev: $15,649,448 | Assets $28,589,614 | EPS -$0.23 | |
| Neuphoria Therapeutics Inc. (NEUP) | 5/20/2025 4:17:59 PM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $15,000,000 | Assets $30,713,319 | EPS $6.55 | Export Earnings Model | |
| Neuphoria Therapeutics Inc. (NEUP) | 5/20/2025 4:15:18 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 3/31/2025 | Rev: $15,000,000 | Assets $30,713,319 | EPS $6.55 | |
| Neuphoria Therapeutics Inc. (NEUP) | 2/14/2025 9:04:08 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 12/31/2024 | Rev: $662,715 | Assets $18,168,220 | EPS -$1.23 | |
| BIONOMICS LIMITED/FI (NEUP) | 11/14/2024 4:25:00 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 9/30/2024 | Assets $22,917,207 | |||
| BIONOMICS LIMITED/FI (NEUP) | 11/12/2024 4:12:21 PM | View | Proxy | SEC | Y 2024 | ||||||
| BIONOMICS LIMITED/FI (NEUP) | 9/30/2024 6:49:11 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 6/30/2024 | Assets $27,649,093 | EPS -$0.01 | ||
| BIONOMICS LIMITED/FI (NEUP) | 1/17/2024 6:15:27 AM | Micro | View | Financials | 20-F/A | SEC | Y 2023 ending: 6/30/2023 | ||||
| BIONOMICS LIMITED/FI (NEUP) | 10/18/2023 6:55:28 AM | Micro | View | Financials | 20-F | SEC | Y 2023 ending: 6/30/2023 | ||||
| Bionomics Limited/FI (NEUP) | 9/28/2023 6:02:04 AM | View | Financials | Earnings | WIRE | Y 2023 | Assets $28,562,948 | Export Earnings Model | |||
| Bionomics Limited/FI (NEUP) | 2/23/2023 6:01:09 AM | View | Financials | Earnings | WIRE | 2Q 2023 | Export Earnings Model | ||||
| BIONOMICS LIMITED/FI (NEUP) | 10/14/2022 9:40:51 AM | Micro | View | Financials | 20-F | SEC | Y 2022 ending: 6/30/2022 |